Summary & Overview
CPT 0557U: Vaginitis Pathogen DNA Panel, PCR-Based
CPT code 0557U designates a Proprietary Laboratory Analyses (PLA) molecular test specific to the HealthTrackRx Vaginitis assay from HealthTrackRx and Thermo Fisher Scientific. The test uses real-time DNA amplification to identify bacteria, yeast, parasites, and viruses in vaginal fluid, reporting each organism as detected or not detected. As a PLA code, 0557U applies only to this unique manufacturer-specific test, which matters for laboratory billing, payer coverage decisions, and claims processing across the nation.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of the clinical context for multiplex molecular testing for vaginitis, the implications of PLA coding for lab and payer workflows, common billing modifiers and procedural considerations, and where to find policy and coverage guidance. The publication addresses benchmarks for utilization and payment structures where available and highlights policy or coding issues that affect laboratory reporting and reimbursement for proprietary assays.
This summary is intended for laboratory billing staff, revenue cycle professionals, and payer policy teams seeking a concise reference to CPT code 0557U and its clinical purpose in detecting infectious causes of vaginitis using a targeted DNA amplification panel.
Billing Code Overview
CPT code 0557U is a Proprietary Laboratory Analyses (PLA) code specific to the HealthTrackRx Vaginitis test from HealthTrackRx and Thermo Fisher Scientific. The assay uses real–time DNA amplification to detect DNA from bacteria, yeast, parasites, and viruses in vaginal fluid. Results for each organism tested are reported as either detected or not detected.
Service type: Molecular diagnostic laboratory test (proprietary PCR-based pathogen panel)
Typical site of service: Clinical laboratory or outpatient specimen collection site
Clinical & Coding Specifications
Clinical Context
A 28-year-old female presents to an outpatient gynecology clinic with a 5-day history of abnormal vaginal discharge, itching, and vaginal odor. The clinician performs a pelvic exam, collects a vaginal swab, and orders the HealthTrackRx Vaginitis test to identify bacterial, fungal, parasitic, or viral DNA using real-time amplification. The specimen is sent to the performing laboratory (HealthTrackRx/Thermo Fisher Scientific). Results are returned as detected/not detected for each organism and used to differentiate bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, and other infectious causes to guide targeted therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Procedure code with no modifier | Use when submitting the PLA test without additional billing modifiers. |
22 | Increased procedural services | Use when test requires substantially greater work or reporting complexity beyond the standard test (rare for an FDA-cleared PLA). |
52 | Reduced services | Use when specimen or testing is incomplete and full analytic procedure was not performed but partial testing occurred. |
53 | Discontinued procedure | Use when testing was started but discontinued due to specimen unsuitability or processing failure. |
90 | Reference (outside) laboratory | Use when test performed by an outside laboratory other than the billing lab (if applicable). |
91 | Repeat clinical diagnostic laboratory test | Use when an identical test is repeated on the same day for verification or quality control. |
59 | Distinct procedural service | Use when billing this PLA in addition to another unrelated diagnostic test on the same day when documentation supports distinct services. |
LT | Left side | Use when laterality is required by payer (not typical for vaginal tests; included for completeness). |
RT | Right side | Use when laterality is required by payer (not typical for vaginal tests; included for completeness). |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Obstetrics & Gynecology | Most common ordering specialty for vaginitis testing. |
| 207L00000X | Family Medicine | Frequently orders vaginitis testing in primary care settings. |
| 207R00000X | Internal Medicine | Orders testing when female patients present with genitourinary symptoms. |
| 364A00000X | Clinical Laboratory | Performing laboratories and pathologists responsible for analyzing specimens. |
| 261QM0800X | Infectious Disease | Consults for recurrent or complicated infections and interpretation of multiplex results. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
N76.0 | Acute vaginitis | Typical indication for ordering a multiplex vaginal pathogen PLA to identify causative organisms. |
N76.1 | Subacute and chronic vaginitis | Used when symptoms are persistent; molecular testing can detect non-culturable organisms. |
N76.2 | Other inflammation of vagina and vulva | Broad category where testing may help determine infectious cause. |
A59.0 | Trichomoniasis | Specific infectious cause detected by DNA amplification on the HealthTrackRx Vaginitis assay. |
B37.3 | Candidiasis of vulva and vagina | Candida species detection is included in the multiplex PLA and guides antifungal therapy. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
87880 | Infectious agent antigen detection by nucleic acid (e.g., direct probe) | Alternative molecular method for detecting specific pathogens; may be ordered if PLA not available. |
88172 | Cytopathology, collection and interpretation (e.g., wet mount) | Wet mount or microscopic exam often performed at point of care alongside molecular testing for immediate clues. |
87070 | Culture, bacterial, any source; supervisory/transfer only | Bacterial culture may be ordered when molecular test results require organism isolation for susceptibility testing. |
87481 | Infectious agent detection by nucleic acid; Chlamydia trachomatis | Specific NAATs for common STIs are often ordered concurrently or instead of a broad PLA. |
87480 | Infectious agent detection by nucleic acid; Trichomonas vaginalis | Targeted NAAT for trichomoniasis commonly performed with vaginitis workup. |